Manufacturer record
Signova Healthcare Pvt. Ltd (Unit-II): regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Signova Healthcare Pvt. Ltd (Unit-II) (Assam) were declared Not of Standard Quality between June 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Signova Healthcare Pvt. Ltd (Unit-II) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Enteric Coated Rabeprazole Sodium & Domperidone Sustained Release Capsules | RDAA24009Mfg 2024-10 · Exp 2026-09 | The sample does not conform to I.P. w.r.to the tests for Dissolution & AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan Tablets IP (Telzasig 20) | TEZC25001Mfg 2025-04 · Exp 2027-03 | Dissolution of TelmisartanDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.